2 five-star stocks to buy

Altium Limited (ASX:ALU) and this ASX share could be five-star stocks to buy right now. Here’s what you need to know about them…
The post 2 five-star stocks to buy appeared first on The Motley Fool Australia. –

Are you looking for some new additions to your portfolio? Then you might want to consider the two fantastic ASX shares named below.

They could be among the best shares available to investors on the Australian share market and capable of generating strong returns for investors over the next decade. Here’s why they might be five-star stocks:

Altium Limited (ASX: ALU)

The first five-star stock to consider buying is Altium. It is a leading electronic design software provider which has exposure to the rapidly growing Internet of Things and artificial intelligence markets. As these markets are underpinning the proliferation of electronic devices globally, demand for software subscriptions looks set to increase materially over the next decade.

In addition to this, Altium’s other businesses, such as workflow solution platform NEXUS and electronic parts search engine Octopart, are supporting it growth and have sizeable market opportunities of their own. A testament to the quality of NEXUS is that it counts Tesla and SpaceX as customers.

Given the favourable industry tailwinds and its leadership position, Altium appears well-placed to achieve its revenue target of US$500 million in FY 2025/26. This will be more than double what it expects to achieve in FY 2021.

Analysts at Morgan Stanley are positive on the company and have an overweight rating and $37.00 price target on its shares.

CSL Limited (ASX: CSL)

Another five-star stock to consider is CSL. This biotherapeutics giant is easily one of the highest quality companies that Australia has ever produced.

When it was founded all the way back in 1916 as the Commonwealth Serum Laboratories, the company was aiming to service the needs of a nation isolated by war. Since then it has become a global giant with a portfolio of life-saving therapies and vaccines.

In fact, that portfolio continues to grow thanks to the company’s investment in research and development. Each year CSL invests somewhere in the region of 10% to 12% of its sales revenue back into its these activities. This helps to ensure that CSL is at the forefront of innovation in the industry.

And while the pandemic has negatively impacted its CSL Behring business, some of this is being offset by increased demand for flu vaccines from its Seqirus business.

Once the pandemic passes and plasma collection headwinds ease, both sides of the business will be pulling together again. Combined with potential launches of new and lucrative therapies, the future looks bright for CSL.

Last month Credit Suisse upgraded CSL’s shares to an outperform rating with a $315.00 price target.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Altium. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 five-star stocks to buy appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!